Skip to content

Retinal Degeneration
- Retinitis Pigmentosa (RP)
- Age-Related Macular Degeneration (AMD)
Our Therapeutic
About LambdaVision
Space Strategy
Contact Us

Drug Companies Explore Making Some of Their Most Lucrative Drugs in Space

Posted on December 5, 2023December 6, 2023

Posted in Media

Post navigation

Nicole Wagner Wants to Help People Regain Vision

LambdaVision Announces First Closing of Seed Round to Advance Artificial Retina Preclinical Studies for Retinal Eye Diseases

4 Research Drive
Woodbridge, CT 06525
info@lambdavision.com

© 2024 LambdaVision, Inc.

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset

Retinal Degeneration
- Retinitis Pigmentosa (RP)
- Age-Related Macular Degeneration (AMD)
Our Therapeutic
About LambdaVision
Space Strategy
Contact Us